Register to participate in an upcoming
peer-to-peer educational forum in your area.
Qsymia is the only FDA-approved, once-daily prescription treatment indicated for chronic weight management.
This program will evaluate the impact of obesity on related risk factors and discuss the clinical guidelines and evolving treatment landscape in obesity. The presentation will review the unique pharmacologic profile of once-daily Qsymia, its clinical efficacy in attaining significant weight loss, and its safety profile. Lastly, the program will review the approach to patient management and dosage flexibility with Qsymia.
To register, please complete the following information. Your registration confirmation will be sent via e-mail.
Please review the list of programs carefully as multiple programs may be offered in your area.